🇺🇸 FDA
Pipeline program

Mesalazine

10085

Approved small_molecule completed

Quick answer

Mesalazine for Irritable Bowel Syndrome With Diarrhoea is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Irritable Bowel Syndrome With Diarrhoea
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials